Pharmacology prefixes and suffixes can help you recognize a medication family. They cannot identify a drug safely on their own. Start with a familiar ending, check the complete generic name, then connect the verified class to the patient's situation.
For example, lisinopril is an ACE inhibitor, losartan is an angiotensin receptor blocker, and metoprolol is a beta blocker. Their names give you useful starting points. They do not tell you the prescribed dose, formulation, administration route, or every precaution.
Sources checked November 9, 2026. This is a nursing study reference; patient care requires the actual medication order, product information, and applicable clinical protocols.
How to use this cheat sheet
- Learn one name pattern with one real generic drug.
- Name the class and explain its main action in your own words.
- Add one important assessment or teaching point from that drug's current reference.
- Test yourself with a similar-looking name that belongs to a different class.
A stem is a deliberately assigned name element that can indicate a relationship between drugs. A suffix is simply an ending; a prefix is at the beginning. These ideas overlap, but every repeated group of letters is not a dependable pharmacology stem. The USAN Council explains how stems group related nonproprietary names, and WHO maintains an INN stem reference and updates.
Common drug prefixes and suffixes: quick reference
Use the middle column as a class clue to verify. The linked examples lead to official drug information. This is a focused study list, not an exhaustive catalog or a rule for every name with the same letters.
| Pattern to notice | Class or family clue | Verified generic example |
|---|---|---|
| -pril | Angiotensin-converting enzyme (ACE) inhibitor | Lisinopril |
| -sartan | Angiotensin II receptor blocker (ARB) | Losartan |
| -olol | Beta blocker | Metoprolol |
| -dipine | Dihydropyridine calcium channel blocker | Amlodipine |
| -vastatin | HMG-CoA reductase inhibitor, commonly called a statin | Atorvastatin |
| -prazole | Proton pump inhibitor (PPI); check for look-alike names | Omeprazole |
| -tidine | Histamine H2 receptor blocker; exceptions exist | Famotidine |
| cef- / ceph- | Cephalosporin antibiotic naming pattern | Cephalexin |
| -cillin | Penicillin antibiotic family | Amoxicillin |
| -floxacin | Familiar fluoroquinolone antibiotic ending | Ciprofloxacin |
| -cycline | Tetracycline antibiotic family | Doxycycline |
| -conazole | An azole antifungal naming clue | Fluconazole |
| -gliptin | Dipeptidyl peptidase-4 (DPP-4) inhibitor | Sitagliptin |
| -gliflozin | Sodium-glucose cotransporter 2 (SGLT2) inhibitor | Empagliflozin |
| -caine | Local anesthetic naming clue; route depends on the product | Lidocaine and prilocaine topical cream |
| -vir | An antiviral naming clue; mechanisms and precautions vary | Acyclovir |
Why use -vastatin instead of just -statin? WHO identifies -vastatin for the cholesterol-lowering family. Nystatin is a polyene antifungal, despite the last six letters of its name. Learn the longer, more informative pattern. WHO's pharmacology teaching guide also includes examples and exceptions for other stems.
Similar endings that can mislead you
Omeprazole and aripiprazole are different drugs
Omeprazole is a PPI that reduces stomach acid. Aripiprazole is an atypical antipsychotic. Although both names end with the letters “prazole,” the longer -piprazole pattern belongs to a different naming family. Read and verify the complete name before choosing a class, assessment, or explanation.
Famotidine does not make every “-tidine” an H2 blocker
Famotidine is an H2 blocker. Azacitidine injection is a demethylation agent used to treat myelodysplastic syndrome. Matching a short ending mechanically would give the wrong answer.
“-mycin” does not identify one antibiotic class
Azithromycin is a macrolide, while vancomycin is a glycopeptide antibiotic. The shared letters do not establish the same mechanism, route, monitoring plan, or adverse effects. Avoid turning “-mycin” into a shortcut for “aminoglycoside.”
“-ide” is too broad to classify a medication
Glipizide is a sulfonylurea; furosemide is a diuretic. A short ending shared by unrelated drugs is a poor memory rule. Use complete names and verified classes instead.
“-mab” does not mean all drugs have the same immune effects
Many established monoclonal antibody names end in -mab. Their targets and uses differ: evolocumab is a PCSK9 inhibitor monoclonal antibody used to lower cholesterol. Do not assume every “-mab” is an immunosuppressant, an IV infusion, or a drug that requires the same premedication or infection screening.
WHO has also introduced -tug, -bart, -mig, and -ment in its newer monoclonal antibody naming scheme. Existing “-mab” names remain familiar, but “all monoclonal antibodies end in -mab” is no longer a useful universal rule.
Connect a verified class to a useful nursing assessment
ACE inhibitors and ARBs: distinguish the class, then review the patient
Use lisinopril → ACE inhibitor and losartan → ARB as separate memory pairs. Lisinopril's drug information lists cough as a possible adverse effect. That does not mean every patient taking an ACE inhibitor will cough, or that an ARB has no important precautions.
For a losartan study card, include blood pressure, renal function, and potassium considerations. The losartan label addresses potassium and kidney monitoring in susceptible patients and warns about drugs or supplements that increase potassium. The patient's condition and prescribed monitoring plan determine the assessment details.
Pregnancy warnings also matter: lisinopril and losartan carry fetal-harm warnings. A suffix study sheet should prompt verification of that warning; it should not recommend a replacement prescription.
Beta blockers: assess the actual medication, not a universal number
Metoprolol slows heart rate and lowers blood pressure. That makes pulse, blood pressure, symptoms, and the prescribed parameters relevant to a nursing review. A naming pattern does not create one heart-rate or blood-pressure cutoff for every patient and every order.
The ending also cannot tell you beta-receptor selectivity. And a beta blocker can have a name outside the familiar pattern: carvedilol is a beta blocker, although it does not end in “-olol.”
Statins: learn the family without inventing a schedule
Atorvastatin is a useful -vastatin example. Its current labeling permits administration at any time of day. Therefore, “all statins must be taken at night” is an unreliable study rule.
For assessment and teaching, review the actual drug's interactions and muscle-related warnings. Atorvastatin's patient information includes unexplained muscle pain, tenderness, or weakness among symptoms requiring prompt medical attention. Laboratory monitoring and administration instructions come from the product information and care plan, rather than the ending alone.
Acid-reducing drugs: name both the mechanism and the example
Pair omeprazole → PPI with famotidine → H2 blocker. Both reduce stomach acid, but they belong to different classes. Use their separate omeprazole and famotidine references to check formulation, interactions, and precautions. Avoid memorizing one acid-reduction percentage or one adverse-effect list for all products.
Antibiotics: class recognition is only the first step
Recognizing amoxicillin, cephalexin, doxycycline, and ciprofloxacin as different antibiotic families helps organize your study. It does not establish that a drug treats a particular organism or is appropriate for a particular patient. Check the actual indication, allergy history, interactions, formulation, and warnings.
For example, ciprofloxacin's drug information includes serious tendon warnings and product-specific instructions about interactions. A generic “separate every antibiotic from every antacid by two hours” rule is not a substitute for reading the actual instructions.
Antifungals and antivirals: keep the distinctions
Fluconazole → antifungal and acyclovir → antiviral are useful recall pairs. Do not extend “-azole” to every similar name: metronidazole is a nitroimidazole antimicrobial. Likewise, recognizing an antiviral name does not establish that every antiviral shares acyclovir's indications or precautions.
A short memory exercise
Cover the class column of the table and say each pair aloud:
- PRIL → ACE; SARTAN → ARB. Keep the two families separate.
- OLOL → check the beta-blocker clue. Remember carvedilol as an exception to that spelling pattern.
- VASTATIN → statin family. Contrast it with nystatin.
- GLIPTIN → DPP-4; GLIFLOZIN → SGLT2. Similar diabetes names can describe different mechanisms.
Then reverse the exercise: start with the class and name a real example. Add an exception card when a name repeatedly fools you. This is more useful than memorizing a large set of endings without complete drug names.
A medication review checklist for nursing students
After noticing a name pattern, answer these questions using the actual order and drug reference:
- Identity: What is the full generic name? Is this a combination product?
- Purpose: Why is this patient receiving it? What response is expected?
- Product: What formulation and route were ordered? Are there specific preparation instructions?
- Assessment: Which symptoms, vital signs, allergies, laboratory findings, or interactions matter for this medication and patient?
- Plan: What do the order and local protocol require? Which findings need clarification with the supervising nurse, prescriber, or pharmacist?
For example, the -caine clue cannot authorize an IV route. Lidocaine and prilocaine are available as a topical anesthetic cream. The complete product and order establish how a medication is used.
Six drug-name practice questions with answers
These original study questions test recognition and its limits. They are not official NCLEX items.
1. Which class matches metoprolol?
A. ACE inhibitor
B. Beta blocker
C. Proton pump inhibitor
D. Antifungal
Answer: B. Metoprolol is a beta blocker. The “-olol” pattern helps recall the class after you verify the complete name. Pulse and blood-pressure considerations come from its effects and the patient's care plan.
2. A student classifies nystatin as a cholesterol-lowering statin. What needs correction?
Answer: Nystatin is a polyene antifungal. Recognize the more informative -vastatin pattern in atorvastatin, and check the actual medication instead of relying on “-statin” alone.
3. Does the spelling of aripiprazole make it a PPI?
Answer: No. Aripiprazole is an atypical antipsychotic. Omeprazole is a PPI. The look-alike ending is a reason to verify the full name, not transfer one drug's class to another.
4. Do azithromycin and vancomycin belong to the same antibiotic class?
Answer: No. Azithromycin is a macrolide; vancomycin is a glycopeptide. “-mycin” does not establish one shared antibiotic mechanism or monitoring plan.
5. A case names losartan, kidney disease, and a potassium supplement. What should the student connect?
Answer: Losartan is an ARB, and its label identifies potassium and renal-function considerations. Review the case's laboratory findings, concurrent products, and prescribed monitoring. The suffix alone cannot establish whether a particular dose should be administered.
6. Are sitagliptin and empagliflozin the same medication class?
Answer: No. Sitagliptin is a DPP-4 inhibitor; empagliflozin is an SGLT2 inhibitor. Distinguishing -gliptin from -gliflozin helps organize the mechanisms, but each drug still needs its own review.
Apply this approach in the cardiac medications practice quiz or antibiotics and antimicrobials quiz. For each question, explain which details came from the drug's identity and which came from the patient scenario.
Frequently asked questions
What drug suffixes should I learn first for nursing school?
Start with the classes in your current course or clinical assignment. A manageable first group is -pril, -sartan, -olol, -vastatin, -prazole, -cillin, -gliptin, and -gliflozin. Learn one complete generic example and one important limitation with each. Add other patterns as you encounter them.
Do all medications in a class have the same suffix?
No. Carvedilol illustrates why the familiar “-olol” ending does not capture every beta blocker. Some families also have more than one naming pattern. Use stems to organize verified knowledge, rather than reject a known class because its name looks different.
Do drug suffixes tell me side effects or hold parameters?
They can prompt recall of a class you have studied. They do not supply a patient's administration decision, numerical hold parameter, laboratory schedule, or full adverse-effect profile. Check the actual drug, formulation, order, patient findings, and local protocol.
Are the four letters after a biologic name another class suffix?
They serve a different purpose. In FDA's biological product naming convention, a hyphenated four-letter suffix distinguishes a product and has no pharmacologic meaning. Do not interpret those letters as its drug class.
Can I make this cheat sheet printable?
Yes. Use your browser's Print option and choose a printer or Save as PDF if available. This saves a copy of the page; no separate download or email signup is required to read this reference.
Official references for checking a drug name
The drug examples above link directly to their MedlinePlus information pages. For naming conventions and the selected prescribing-information checks, use:
- AMA: United States Adopted Names approved stems.
- WHO: INN stems and current updates.
- WHO: Learning clinical pharmacology using INNs and their stems, including examples and spelling exceptions.
- WHO: New monoclonal antibody nomenclature scheme.
- DailyMed: Losartan potassium prescribing information.
- DailyMed: Atorvastatin calcium prescribing information.
- DailyMed: Amlodipine besylate clinical pharmacology.
- FDA: Nonproprietary naming of biological products.
